RxDoctor Payments Data

Leigh Cordill, PA

Medical · Monroe, LANPI 1528126588

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.0% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Johnson & Johnson at 24.2% of the total. Reporting peaked in 2022 at $1,121 and has fallen 52.1% since, to $537 in 2025.

$3,706in general payments, 2019–2025

Across 196 payments — averaging $18.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$899
  • Sanofi$651
  • AbbVie$398
  • Lilly USA, LLC$371
  • Sun Pharmaceutical Industries Inc.$272
  • Amgen$170
  • plus $945 from 12 others

What the payments were for

  • Food & beverage$3,55896%
  • Education$1484%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,706 in reported general payments places this provider in the 80th percentile of 253 medical providers in Louisiana.

See all medical providers in Louisiana

Medicare billing

Part B allowed, 2024
$37,192
Medicare patients
239
Services billed
1,205

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil55$3,757
Ketoconazole58$1,172
Fluocinonide27$1,109
Mometasone Furoate50$1,010
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc24$646
Triamcinolone Acetonide87$640
Betamethasone Dipropionate19$619
Hydrocortisone117$593
Doxycycline Hyclate32$469
Alclometasone Dipropionate14$466
Clobetasol Propionate15$436
Mupirocin50$372
Nystatin15$123
Cephalexin12$57

Paid to pharmacies, not to this prescriber.

Other medical in Monroe

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →